Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: Description of a new case and review of the literature

Infection

Volumn 41, Issue 6, 2013, Pages 1183-1187

  Schwarze Zander, C ^a   Klingmuller D ^a   Klumper J ^b   Strassburg, C P ^a   Rockstroh, J K ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b NONE

Author keywords

Cushing syndrome; HIV; Ritonavir; Triamcinolone

Indexed keywords

ACICLOVIR; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; HYDROCORTISONE; POTASSIUM; RALTEGRAVIR; RITONAVIR; SAQUINAVIR; TRIAMCINOLONE;

ADRENAL SUPPRESSION; ADULT; CASE REPORT; CD4 LYMPHOCYTE COUNT; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; DISEASE COURSE; DISEASE SEVERITY; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOW BACK PAIN; LYMPHOCYTOPENIA; MALE; MEDICAL HISTORY; POTASSIUM BLOOD LEVEL; RADICULOPATHY; REVIEW; VERTEBRAL CANAL STENOSIS; VIRUS LOAD;

ADULT; ANTI-INFLAMMATORY AGENTS; CUSHING SYNDROME; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; RITONAVIR; TRIAMCINOLONE;

EID: 84890436387     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0506-z     Document Type: Review

References (14)

1. Kim JH, Psevdos G, Gonzalez E, Singh S, Kilayko MC, Sharp V. All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in New York City in the era of highly active antiretroviral therapy (HAART). Infection. 2013;41:545-51.
2. Ramanathan R, Pau AK, Busse KH, Zemskova M, Nieman L, Kwan R, Hammer JH, Mican JM, Maldarelli F. Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir. Clin Infect Dis. 2008;47:97-9.
3. Yombi JC, Maiter D, Belkhir L, Nzeusseu A, Vandercam B. Iatrogenic Cushing's syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir. Clin Rheumatol. 2008;27[Suppl 2]:S79-82.
4. Dort K, Padia S, Wispelwey B, Moore CC. Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case report. AIDS Res Ther. 2009;6:10.
5. Danaher PJ, Salsbury TL, Delmar JA. Metabolic derangement after injection of triamcinolone into the hip of an HIV-infected patient receiving ritonavir. Orthopedics. 2009;32:450.
6. Grierson MJ, Harrast MA. Iatrogenic Cushing syndrome after epidural steroid injections for lumbar radiculopathy in an HIV-infected patient treated with ritonavir: a case report highlighting drug interactions for spine interventionalists. PM R. 2012;4:234-7.
7. Levine D, Ananthakrishnan S, Garg A. Iatrogenic Cushing syndrome after a single intramuscular corticosteroid injection and concomitant protease inhibitor therapy. J Am Acad Dermatol. 2011;65:877-8.
8. Albert NE, Kazi S, Santoro J, Dougherty R. Ritonavir and epidural triamcinolone as a cause of iatrogenic Cushing's syndrome. Am J Med Sci. 2012;344:72-4.
9. Maviki M, Cowley P, Marmery H. Injecting epidural and intra-articular triamcinolone in HIV-positive patients on ritonavir: beware of iatrogenic Cushing's syndrome. Skeletal Radiol. 2013;42:313-5.
10. Fessler D, Beach J, Keel J, Stead W. Iatrogenic hypercortisolism complicating triamcinolone acetonide injections in patients with HIV on ritonavir-boosted protease inhibitors. Pain Physician. 2012;15:489-93.
11. Hirsch HH, Battegay M. Lipodystrophy syndrome by HAART in HIV-infected patients: manifestation, mechanisms and management. Infection. 2002;30:293-8.
12. Manchikanti L, Pampati V, Falco FJ, Hirsch JA. Growth of spinal interventional pain management techniques: analysis of utilization trends and medicare expenditures 2000 to 2008. Spine. 2013;38:157-68.
13. GlaxoSmithKline. GlaxoSmithKline (GSK) clinical study register. Available at: http://www.gsk-clinicalstudyregister.com.
14. Villikka K, Varis T, Backman JT, Neuvonen PJ, Kivistö KT. Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivo. Eur J Clin Pharmacol. 2001;57:457-60.